By Eduardo Bacci — The Investigative Journal
The week ending May 13, 2026 produced an unusually dense pile of consequential corporate disclosures, led by a material ransomware filing from a critical-infrastructure pharmaceutical packager, an executive shake-up at an embattled electric-vehicle holding, and a fresh round of nine-figure pay packages putting the largest U.S. banks back in the say-on-pay crosshairs. Below, TIJ examines seven filings that landed on the SEC’s EDGAR system between May 1 and May 13, 2026, and weighs what each tells us about how American boardrooms are managing risk, capital, and accountability heading into the back half of the 2026 proxy season.
1. West Pharmaceutical Services (NYSE: WST) — A material ransomware event hits the pharma supply chain
The week’s most consequential disclosure came from West Pharmaceutical Services, the Pennsylvania-based maker of stoppers, seals, and injection components used in roughly half of the world’s injectable drug packaging. In an 8-K filed May 7, 2026, the company disclosed it had determined it experienced “a material cybersecurity attack,” after detecting an intrusion on May 4. Records indicate certain data was exfiltrated, certain systems were encrypted, and West took its systems offline globally for containment, engaging Palo Alto Networks’ Unit 42 and notifying law enforcement.
The dollar exposure is not yet quantified — West stated it has “not yet determined” the financial impact — but the strategic significance is hard to overstate. West supplies primary packaging components to nearly every major vaccine and biologic on the U.S. market, and the company’s filings indicate the incident “temporarily disrupted business operations globally.” Industry comparisons are instructive: the 2024 Change Healthcare ransomware event cost UnitedHealth more than $2.4 billion in direct costs, and the 2023 Clorox cyberattack erased roughly a quarter of one quarter’s sales. WST’s market capitalization sits near $20 billion; even a single-digit-percentage revenue disruption would dwarf the company’s typical quarterly free cash flow.
The filing also illustrates how the SEC’s 2023 cybersecurity disclosure rule is reshaping incident transparency. Three days elapsed between detection and materiality determination, and West met the four-business-day disclosure window — but the company has been deliberately sparse on attacker attribution, ransom demands, and the nature of the exfiltrated data, framing the omissions as part of an ongoing investigation. Investors await West’s next operational update, which the company indicated would come as more systems are restored.
2. Goldman Sachs (NYSE: GS) — A $47M pay package and an $80M retention bonus head to a contested vote
Goldman Sachs’s definitive proxy statement, filed March 19 and now headed toward an April 29, 2026 advisory vote in Salt Lake City, drew renewed scrutiny this week as proxy advisers finalized their recommendations. CEO David Solomon’s 2025 total compensation came in at $47 million, a 20.5% increase over his prior year, alongside an $80 million retention award that does not vest until January 2030 and is contingent on continued service. President John Waldron received a comparable retention package, bringing combined retention awards close to $160 million.
Filings indicate Goldman’s lead director, compensation committee chair, and investor relations team participated in more than 120 meetings with shareholders representing over 45% of outstanding shares ahead of the vote. Proxy adviser ISS has flagged the retention awards as misaligned with pay-for-performance principles, citing the absence of performance-based vesting conditions on the retention grants themselves. Glass Lewis raised similar concerns. For context, median S&P 500 CEO pay reached roughly $16.4 million in the latest cycle — making Solomon’s package nearly three times the index median and likely the highest among major U.S. bank CEOs in 2026.
The Solomon package is a useful test case for the broader 2026 proxy season. Reports indicate that a subset of large issuers fell below the 70% say-on-pay support threshold last year, which under updated ISS policy triggers heightened scrutiny of board responsiveness. A weak vote at Goldman would compound questions already raised by Glass Lewis’s 2026 policy update, which expanded the universe of “otherwise problematic” pay programs that can draw against-recommendations even where total compensation appears justified.
3. JPMorgan Chase (NYSE: JPM) — Dimon’s $43M up for shareholder vote next week
JPMorgan Chase’s annual meeting on May 19, 2026 will deliver the next major data point on big-bank pay. According to the bank’s definitive proxy, CEO Jamie Dimon’s 2025 total compensation was set at $43 million — a 10.3% bump over the prior year — comprising $1.5 million in salary, a $5 million cash bonus, and $36.5 million in performance share units. Shareholders will also vote on 11 directors and the ratification of PricewaterhouseCoopers as the auditor.
The vote arrives against an unusual backdrop. Earlier in 2026, Dimon publicly criticized proxy advisers ISS and Glass Lewis as “incompetent,” and JPMorgan Asset Management announced it would conduct independent stewardship research rather than rely on either firm’s benchmark recommendations. Records show that in 2022 only 31% of investors backed Dimon’s pay package — the bank’s first say-on-pay defeat since the advisory vote was introduced in 2009. Whether 2026 produces a repeat will be a leading indicator of how investors balance record bank profitability against pay-design concerns.
4. Faraday Future Intelligent Electric (NASDAQ: FFAI) — Founder consolidates control
Faraday Future disclosed in an 8-K dated May 5, 2026 that its board accepted the resignation of Matthias Aydt as Co Global Chief Executive Officer and appointed founder Yueting “YT” Jia as sole Chief Executive Officer. Jiawei Wang, the company’s prior Global President, was promoted to Global Executive Chairman. The filing concentrates operational authority in Jia, whose tenure at Faraday has been marked by repeated capital raises, dilutive financings, and ongoing concerns over going-concern viability.
The disclosure warrants scrutiny because Faraday’s recent 10-K, filed earlier this spring, carried risk factors flagging substantial doubt about the company’s ability to continue as a going concern, and noted material weaknesses in internal controls over financial reporting. Records suggest the company has burned through more than $4 billion in cumulative losses since 2014 while delivering only a small fleet of vehicles. The leadership concentration eliminates an independent operational counterweight at a moment when investors might reasonably expect the opposite.
5. SunPower (NASDAQ: SPWR) — Reorganized solar company loses a CFO
The post-bankruptcy reorganization of SunPower continues to throw off governance signals. An 8-K filed May 12, 2026 disclosed that Wendell Laidley resigned as Chief Financial Officer effective May 7, 2026, with CEO Thurman J. Rodgers — the company’s chief executive and major financial backer — being appointed as Principal Financial Officer. The same filing reported a Q1 2026 loss alongside roughly $9.9 million in cost reductions. The dual-hatting of CEO and Principal Financial Officer is a structure that typically draws governance concerns; ISS guidelines treat combined CEO/CFO roles as warranting heightened audit-committee oversight, particularly for companies emerging from insolvency.
For context, SunPower exited Chapter 11 in 2024 under a restructuring that handed Complete Solaria — Rodgers’s venture — control of the brand. The CFO vacancy comes as the residential solar industry remains under pressure from tariff-driven module-cost inflation and the unwinding of certain Inflation Reduction Act incentives. Filings indicate the company is searching for a permanent CFO and that Rodgers’s appointment is interim.
6. Micron Technology (NASDAQ: MU) — CEO sells $21.5M in stock as memory boom peaks
Form 4 filings show Micron Technology CEO Sanjay Mehrotra sold 39,995 shares of common stock on May 1, 2026 in a series of open-market transactions priced between $511.91 and $545.39, generating total proceeds of approximately $21,450,554. The sales were executed under a Rule 10b5-1 plan adopted on January 30, 2026. The transactions reduced Mehrotra’s directly-held position meaningfully but left his total beneficial ownership well above the company’s stock-ownership guideline thresholds.
The context matters: Micron’s stock has more than doubled over the past 12 months on surging demand for high-bandwidth memory used in AI accelerators. Industry analysts have variously called the current memory cycle either an early-innings boom or a peak. Records suggest Mehrotra has sold under similar 10b5-1 plans in each of the past three years. Form 4 sales executed under prearranged plans are not, on their face, signals of insider concern, but the timing — at the apex of the most lucrative memory cycle in a decade — will draw analyst attention. Other notable May insider sales included JFrog CEO Shlomi Ben Haim disposing of 25,000 ordinary shares and Zoom Communications CEO Eric Yuan unloading 24,200 Class A shares.
7. Dominion Energy (NYSE: D) and Eversource Energy (NYSE: ES) — Independent-chair proposals defeated
Two large utilities held annual meetings in the first week of May with directionally similar outcomes. Dominion Energy, in an 8-K reporting its May 5, 2026 meeting, disclosed that its advisory Say on Pay vote was approved with roughly 640.9 million votes for and 31.9 million against, a support rate near 95%. Three shareholder proposals were defeated: an independent-chair policy (164.2 million for; 506.4 million against), a proposal seeking a report on ESG and diversity metrics in executive compensation, and a proposal calling for additional shareholder engagement channels.
Eversource Energy‘s May 6, 2026 annual meeting produced a similar result on the independent-chair question, which failed to win majority support. The pattern reinforces a broader 2026 proxy season trend: ESG-style shareholder proposals filed at U.S. companies are down 47% year-over-year, according to Ballotpedia data, and DEI metrics in S&P 500 compensation programs have fallen from 57% to 22% of programs. The combination of SEC no-action rule changes, ISS and Glass Lewis policy recalibrations, and shifting investor priorities is materially compressing the universe of ESG votes that reach proxies — and the few that do are increasingly failing to clear majority thresholds.
What warrants deeper TIJ investigation
Three of this week’s filings stand out for follow-up reporting. West Pharmaceutical‘s eventual quantification of the ransomware impact, including any disclosure of ransom payment, attacker attribution, and downstream supply effects on injectable biologics, will test whether the SEC’s cybersecurity rule produces transparency that investors and patients can actually use. Goldman Sachs’s April 29 vote — and the board’s response if support falls below the 70% threshold — will set a benchmark for the proxy season’s biggest unresolved pay fight. And Faraday Future’s consolidation of CEO authority in a founder with a history of capital-structure concerns merits forensic review of related-party transactions, going-concern disclosures, and the independence of the remaining board.
Each of these is a story TIJ will continue tracking through the EDGAR pipeline, proxy season vote tallies, and follow-on disclosures in 8-Ks and 10-Qs over the coming weeks.
Sources and primary filings:
- West Pharmaceutical Services 8-K (May 7, 2026) — SEC EDGAR filings for WST
- Goldman Sachs DEF 14A (filed March 19, 2026) — SEC EDGAR filings for GS
- JPMorgan Chase DEF 14A (2026) — SEC EDGAR filings for JPM
- Faraday Future Intelligent Electric 8-K (May 5, 2026) — SEC EDGAR filings for FFAI
- SunPower 8-K (May 12, 2026) — SEC EDGAR filings for SPWR
- Micron Technology Form 4 (May 1, 2026) — SEC EDGAR Form 4 filings for MU
- Dominion Energy 8-K (May 5, 2026) — SEC EDGAR filings for Dominion Energy
- Eversource Energy proxy meeting results (May 6, 2026) — SEC EDGAR filings for Eversource Energy
Disclaimer: This article summarizes information drawn from public SEC filings and reputable financial press. It is not investment advice and does not constitute legal analysis. Allegations and pending matters are noted as such; nothing in this article should be read as a finding of wrongdoing absent an adjudicated determination.